Journal of Enzyme Inhibition and Medicinal Chemistry · 2018 · 90 citations · 40 references
MedicineMedicinal ChemistryPharmacologyApoptosisCancer PharmacologyDrug DesignApoptosis In CancerApoptosis PharmacologyAnnexin V AssaysAnti-apoptotic AgentsAnticancer ActivityCancer Cell ApoptosisIndole ChemistryIndole DerivativesMolecular HybridsPro-apoptotic Agents
=1.04 µM), which displayed a significant decrease of cell population in the G2/M phase and significant increase in the early and late apoptosis by 19-folds in Annexin-V-FTIC assay. Also, 6n increased the expression of caspase-3, caspase-9, cytochrome C and Bax and decreased the expression of Bcl-2. Moreover, compounds 6i, 6j, 6n and 6q generated ROS by significant increase in the level of SOD and depletion of the levels of CAT and GSH-Px in MCF-7.
40
H. Aebi · Methods in enzymology on CD-ROM/Methods in enzymology · 1984 · 25.1K citations
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Philip Skehan, Ritsa Storeng, Dominic A. Scudiero et al. · JNCI Journal of the National Cancer Institute · 1990 · 9.8K citations
Medicine, Oncology, Pharmacology +10